RECENT PAST NEWS IN MDR-TB

Fighting drug-resistant TB was costly. Here's how that's changed

WHO releases updated guidelines on tuberculosis preventive treatment

TB diagnosis and drug resistance testing can be reduced to just 23 hours

Major advance in the fight against MDR-TB: four new short and effective treatments from independent clinical trials approved by the WHO

The Competition Commission of South Africa has initiated another important complaint involving TB drugs

Relief in South Africa after J&J reversal allows key tuberculosis drug production at lower prices

A survey of the effectiveness of centralized consilia in providing advice on drug-resistant TB

Symposium on Emerging Resistance to Novel Tuberculosis Drugs

Treatment Action Group - Report from the 1/4/6×24 Campaign

Treat Action Group 2023 Pipeline Report

The Rejection of the Bedaquiline Patent Opposition in Indonesia Raises the Risk of Difficulty in Accessing Optimal TB Therapy

To Prepare For The Next Pandemic, We Must Spend Now On TB And Other Major Diseases

WHO European Region: Data collection guide - indicators for meaningful involvement of civil society in TB response

"Poverty is the disease,TB is the symptom" -Vidya Krishnan

endTB Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options

New preventive treatment for children cuts the risk of drug-resistant tuberculosis by more than half

Ending TB Is Within Reach — So Why Are Millions Still Dying?

TAG's 2023 Pipeline Report: TB vaccines

Global Fund, Stop TB Partnership and USAID Announce New Collaboration with Danaher

Lancet Commission calls for renewed global response on TB